Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Department of Oncology, Academy of Medical and Pharmaceutical Sciences of Zhengzhou University, Zhengzhou, People's Republic of China.
Hematology. 2021 Dec;26(1):37-42. doi: 10.1080/16078454.2020.1866304.
A new regulatory subpopulation of innate lymphoid cells (ILCs), regulatory innate lymphoid cells (ILCregs), has been identified with both innate lymphoid cells and regulatory cells characteristics. The purpose of this study is to explore ILCregs and its associated miRNAs in patients with aplastic anemia (AA) by evaluating ILCregs frequency, associated miRNA quantification, and their significance.
Using 4 color combinations of surface and intracellular antibody staining, the CD45+Lin-CD127+IL-10+ ILCregs from 30 healthy donors and 30 patients newly diagnosed with AA were measured by flow cytometry. Bone marrow cells were studied by next-generation sequence miRNAs quantification.
Our results showed that the frequency of ILCregs in bone marrow cells from healthy donors (HD) and AA patients were 0.703 ± 0.941 and 0.171 ± 0.233%, respectively. The frequencies of ILCregs in AA patients were significantly lower than that in HD ( <0.05). miRNA detection results showed different expression patterns in the AA patient group comparing with HD. Comparing with HD, there were 52 miRNAs up-regulated and 130 miRNAs down-regulated from AA patients. Analysis of miRNAs from ILCregs associated genes demonstrated different miRNAs expression patterns between HD and AA patient.
The present study demonstrated the deficiency of ILCregs and differential expression pattern of ILCregs gene-related miRNA in patients with AA. Further studies need to be done to explore the clinical significance of ILCregs and related miRNAs in patients with AA with large samples size and clinical follow-up.
已鉴定出具有先天淋巴细胞和调节细胞特征的先天淋巴细胞(ILC)新调节亚群,即调节性先天淋巴细胞(ILCreg)。本研究旨在通过评估 ILCreg 频率、相关 miRNA 定量及其意义,来探索再生障碍性贫血(AA)患者中的 ILCreg 及其相关 miRNA。
使用表面和细胞内抗体染色的 4 种组合,通过流式细胞术测量 30 名健康供体和 30 名新诊断为 AA 的患者的 CD45+Lin-CD127+IL-10+ ILCreg。通过下一代测序 miRNA 定量研究骨髓细胞。
我们的结果表明,健康供体(HD)和 AA 患者骨髓细胞中 ILCreg 的频率分别为 0.703±0.941%和 0.171±0.233%。AA 患者的 ILCreg 频率明显低于 HD(<0.05)。与 HD 相比,AA 患者组的 miRNA 检测结果显示出不同的表达模式。与 HD 相比,AA 患者有 52 个 miRNA 上调和 130 个 miRNA 下调。对 ILCreg 相关基因的 miRNA 分析表明,HD 和 AA 患者之间存在不同的 miRNA 表达模式。
本研究表明 AA 患者中 ILCreg 缺乏和 ILCreg 基因相关 miRNA 的差异表达模式。需要进一步研究以探讨 ILCreg 和相关 miRNA 在 AA 患者中的临床意义,样本量较大且具有临床随访。